The Problem of Structural Cardiovascular Disease
Structural Cardiovascular Disease includes all anatomic abnormalities of the heart muscle, heart valves and great arteries that impair cardiac function and/or are associated with catastrophic life-terminating events. The most common forms of structural cardiovascular disease include:
- Heart Failure (Dilated Left Ventricle after a Myocardial Infarction)
- Valvular Disease (Aortic, Mitral, Pulmonic, Tricuspid)
- Congenital Heart Disease
- Aortic Aneurysms
Who We Are
Under the direction of Drs. Robert and Joseph Gorman, the Gorman Cardiovascular Research Group is a multi-disciplinary team of surgeons, interventional cardiologists, engineers, computer scientists and imaging specialists focused on understanding and treating structural cardiovascular disease. Our work has been continuously funded for 15 years by the National Institutes of Health, American Heart Association and the W.W. Smith Foundation as well as by corporate and philanthropic sponsors.
What We Do
The principal goal of our group is to develop more effective and when possible less invasive approaches to the treatment of structural cardiovascular disease. We are committed to:
- A better understanding of all aspects of structural cardiovascular disease.
- The design, development and commercialization of new, effective and less invasive treatment strategies for structural cardiovascular disease.
- The development and maintenance of clinically relevant large animal models of structural cardiovascular disease.
- Testing of emerging technologies developed by corporate/ industry colleagues.
- The design, development and implementation of new and novel imaging modalities that can guide emerging therapeutic technologies and allow for better clinical risk stratification for individual patients.
- The education of surgical, medical, engineering and radiology trainees at all academic levels.